Trial · NCT01767636
Adverse events76
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 76
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Treatment (Pazopanib Hydrochloride) | 3 | 35 | 5 |
| other | Hypothyroidism | Endocrine disorders | Treatment (Pazopanib Hydrochloride) | 4 | 35 | 7 |
| other | Blurred vision | Eye disorders | Treatment (Pazopanib Hydrochloride) | 1 | 35 | 1 |
| other | Dry eye | Eye disorders | Treatment (Pazopanib Hydrochloride) | 1 | 35 | 1 |
| other | Watering eyes | Eye disorders | Treatment (Pazopanib Hydrochloride) | 1 | 35 | 2 |
| other | Abdominal pain | Gastrointestinal disorders | Treatment (Pazopanib Hydrochloride) | 6 | 35 | 7 |
| other | Constipation | Gastrointestinal disorders | Treatment (Pazopanib Hydrochloride) | 1 | 35 | 1 |
| other | Diarrhea | Gastrointestinal disorders | Treatment (Pazopanib Hydrochloride) | 23 | 35 | 95 |
| other | Esophageal pain | Gastrointestinal disorders | Treatment (Pazopanib Hydrochloride) | 1 | 35 | 3 |
| other | Flatulence | Gastrointestinal disorders | Treatment (Pazopanib Hydrochloride) | 2 | 35 | 4 |
| other | Gastroesophageal reflux disease | Gastrointestinal disorders | Treatment (Pazopanib Hydrochloride) | 1 | 35 | 1 |
| other | Gastrointestinal disorders - Oth spec | Gastrointestinal disorders | Treatment (Pazopanib Hydrochloride) | 1 | 35 | 1 |
| other | Gastroparesis | Gastrointestinal disorders | Treatment (Pazopanib Hydrochloride) | 1 | 35 | 2 |
| other | Mucositis oral | Gastrointestinal disorders | Treatment (Pazopanib Hydrochloride) | 1 | 35 | 1 |
| other | Nausea | Gastrointestinal disorders | Treatment (Pazopanib Hydrochloride) | 9 | 35 | 20 |
| other | Vomiting | Gastrointestinal disorders | Treatment (Pazopanib Hydrochloride) | 6 | 35 | 8 |
| other | Edema limbs | General disorders | Treatment (Pazopanib Hydrochloride) | 1 | 35 | 1 |
| other | Fatigue | General disorders | Treatment (Pazopanib Hydrochloride) | 31 | 35 | 190 |
| other | Gen disord and admin site conds-Oth spec | General disorders | Treatment (Pazopanib Hydrochloride) | 1 | 35 | 2 |
| other | Pain | General disorders | Treatment (Pazopanib Hydrochloride) | 1 | 35 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01767636/events